Home - Products - Angiogenesis - PDE - Enpp-1-IN-16

Enpp-1-IN-16

CAS No. 2289739-47-3

Enpp-1-IN-16( —— )

Catalog No. M37145 CAS No. 2289739-47-3

Enpp-1-IN-16 is an inhibitor targeting ENPP1 with potential anti-cancer activity.Enpp-1-IN-16 can be used to study insulin resistance in relation to type II diabetes mellitus and various ENPP1-mediated diseases in the chondrocalcinosis and osteoarthritis classes.

Purity : >98% (HPLC)

COA

Datasheet

HNMR

HPLC

MSDS

Handing Instructions

Size	Price / USD	Stock	Quantity
2MG	47	In Stock
5MG	76	In Stock
10MG	122	In Stock
25MG	275	In Stock
50MG	423	In Stock
100MG	669	In Stock
200MG	Get Quote	In Stock
500MG	1386	In Stock
1G	Get Quote	In Stock

Get Quotation Bulk Inquiry Add to Cart

Biological Information

Product Name

Enpp-1-IN-16
Note

Research use only, not for human use.
Brief Description

Enpp-1-IN-16 is an inhibitor targeting ENPP1 with potential anti-cancer activity.Enpp-1-IN-16 can be used to study insulin resistance in relation to type II diabetes mellitus and various ENPP1-mediated diseases in the chondrocalcinosis and osteoarthritis classes.
Description

Enpp-1-IN-16 (compound 54) is an ENPP1 inhibitor. Enpp-1-IN-16 has the potential to study cancer, especially in cases of high ENPP1 expression or elevated cytoplasmic DNA levels. Enpp-1-IN-16 can also be used in other diseases mediated by ENPP1, such as bacterial or viral infections, insulin resistance and type II diabetes, chondrocalcinosis and osteoarthritis, calcium pyrophosphate deposition disorder (CPPD), low Phosphatase disease and soft tissue calcification disorders.
In Vitro

——
In Vivo

——
Synonyms

——
Pathway

Angiogenesis
Target

PDE
Recptor

PDE
Research Area

——
Indication

——

Chemical Information

CAS Number

2289739-47-3
Formula Weight

428.52
Molecular Formula

C23H32N4O4
Purity

>98% (HPLC)
Solubility

In Vitro:?DMSO : 2 mg/mL (4.67 mM; Ultrasonic )
SMILES

O=C(OC(C)(C)C)N1CCC2(C1)CCN(C=3N=CN=C4C=C(OC)C(OC)=CC43)CC2
Chemical Name

——

Shipping & Storage Information

Storage

(-20℃)
Shipping

With Ice Pack
Stability

≥ 2 years

Reference

1. Derek A Cogan, et al. Imino sulfanone inhibitors of enpp1. WO2021225969A1.

Calculator

Molecular Weight Calculator

Dilution Calculator

Molarity Calculator

molnova catalog

related products

MBCQ

MBCQ is an inhibitor of cGMP-specific phosphodiesterase PDE5.MBCQ, a selective PDE5 inhibitor, significantly decreased the EC(50) values for GTN-induced relaxation in both tolerant and nontolerant tissues, but with the greatest relative shift occurring in tolerant veins.
Ensifentrine

Ensifentrine is a PDE3/4 inhibitor, although its affinity for PDE3(IC50: 0.4 nM) is 3,440 times higher than that for PDE4(IC50: 1479 nM), that is under clinical development for the treatment of asthma and COPD and, potentially, cystic fibrosis.
Enoximone

Enoximone is a selective inhibitor of phosphodiesterase III (PDE3), with treatment of congestive heart failure.

Sign In Join Free